The Relative Risk of Immune-Related Liver Dysfunction of PD-1/PD-L1 Inhibitors Versus Chemotherapy in Solid Tumors: A Meta-Analysis of Randomized Controlled Trials

Background: Immune checkpoint inhibitors (ICIs) have made a significant breakthrough in the treatment of solid tumors; however, their use also generates unique immune-related adverse effects (irAEs). Here, we performed a systematic review and meta-analysis to assess the risk of immune-related liver...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Siyao, Yang, Qinyan, Shu, Xiaochen, Lang, Jinyi, Lu, Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767975/
https://www.ncbi.nlm.nih.gov/pubmed/31607917
http://dx.doi.org/10.3389/fphar.2019.01063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767975/
https://www.ncbi.nlm.nih.gov/pubmed/31607917
http://dx.doi.org/10.3389/fphar.2019.01063

Ejemplares similares